BLCO
Bausch & Lomb Corp
Key Financials
Net Income
$-360000000
↓ 13.6%
Operating Income
$113.0M
↓ 30.2%
Revenue
$5.1B
↑ 6.5%
EPS (Diluted)
$-1.02
↓ 13.3%
Total Liabilities
$7.5B
↑ 8.3%
Total Assets
$14.0B
↑ 4.1%
Shareholders' Equity
$6.4B
↓ 0.4%
Cash & Equivalents
$383.0M
↑ 25.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/16/2026 | View on SEC |
| SD | 6/1/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BLCO |
| Company Name | Bausch & Lomb Corp |
| CIK | 1860742 |
| Sector | Ophthalmic Goods |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3851 |
| SIC Description | Ophthalmic Goods |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 908-541-5456 |